PROSPECTUS SUPPLEMENT
(To Prospectus dated April 29, 2019)
$225,804,767
Retail Opportunity Investments Corp.
Common Stock
On May 1, 2018, we entered into separate sales agreements (as may be amended from time to time), each of which we refer to as a Sales Agreement and together as the Sales Agreements, with Capital One Securities, Inc., or Capital One Securities, Jefferies LLC, or Jefferies, KeyBanc Capital Markets Inc., or KeyBanc Capital Markets, Raymond James & Associates, Inc., or Raymond James, and Robert W. Baird & Co. Incorporated, or Baird, respectively, each of which we refer to individually as an Agent and together as the Agents, relating to the shares of common stock offered by this prospectus supplement. In accordance with the terms of the Sales Agreements, we may offer and sell shares of our common stock having an aggregate offering price of up to $250,000,000 from time to time through any of the Agents, as our sales agents. Prior to the date of this prospectus supplement, we offered and sold shares of our common stock having an aggregate offering price of approximately $24,195,233 pursuant to the Sales Agreements. This prospectus supplement and the accompanying prospectus relate to the offer and sale from time to time of shares of our common stock having an aggregate offering price of up to $225,804,767, which amount was previously offered for sale but remains unsold under a prospectus supplement dated May 1, 2018 to the prospectus dated May 23, 2016.
Sales of the shares, if any, will be made by means of ordinary brokers’ transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.
We will pay each Agent a commission of up to 2.0% of the gross sales price of shares sold through it as sales agent under the applicable Sales Agreement.
Under the terms of each Sales Agreement, we also may sell shares of our common stock to the applicable Agent as principal for its own account at a price agreed upon at the time of sale. If we sell shares of our common stock to an Agent as principal, we will enter into a separate terms agreement with such Agent, and we will describe this agreement in a separate prospectus supplement or pricing supplement.
None of the Agents is required to sell any specific number or dollar amount of shares of our common stock but each Agent will use its commercially reasonable efforts, as our sales agent and subject to the terms of the applicable Sales Agreement, to sell the shares offered by this prospectus supplement, as instructed by us. The offering of common stock pursuant to each Sales Agreement will terminate upon the earlier of (1) the sale of shares of our common stock subject to the Sales Agreements having an aggregate offering price of $250,000,000 and (2) with respect to a particular Sales Agreement, the termination of such Sales Agreement by us or by the applicable Agent.
Our common stock is listed on the NASDAQ Global Select Market, or NASDAQ, under the symbol “ROIC.” The last reported closing sale price of our common stock on NASDAQ on April 26, 2019 was $17.62 per share.
There are restrictions on ownership and transfer of our common stock intended, among other purposes, to preserve our qualification as a real estate investment trust. See “Description of Common Stock—Restrictions on Ownership and Transfer” in the accompanying prospectus.
Investing in our common stock involves risks. See “Supplemental Risk Factors” beginning onpage S-3 of this prospectus supplement, as well as the “Risk Factors” incorporated by reference from our Annual Report on Form10-K for the year ended December 31, 2018, before making a decision to invest in our common stock.
Neither the U.S. Securities and Exchange Commission nor any state or other securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | |
Baird | | Capital One Securities | | Jefferies | | KeyBanc Capital Markets | | Raymond James |
The date of this prospectus supplement is April 29, 2019.